Alaunos Therapeutics, Inc. Cash and Cash Equivalents
Alaunos Therapeutics, Inc. (TCRT) had Cash and Cash Equivalents of $124.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $124.00K.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $354.00K.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $1.39M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $1.94M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $124.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $354.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $1.39M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $1.94M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.88M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $319.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.09M 10-K · filed 2026-03-31 |
| 2024-09-30 | $1.68M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $2.46M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $4.14M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $6.06M 10-K · filed 2025-03-31 |
| 2023-09-30 | $11.94M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $18.32M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $23.50M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $39.06M 10-K · filed 2024-04-01 |
| 2022-09-30 | $37.81M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $60.01M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $68.25M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $76.05M 10-K · filed 2023-03-07 |
| 2021-09-30 | $91.72M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $76.75M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $100.06M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $115.07M 10-K · filed 2022-03-30 |
| 2020-09-30 | $135.47M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $153.52M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $171.00M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $79.74M 10-K · filed 2021-03-01 |
| 2019-09-30 | $88.42M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $43.56M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $51.49M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $61.73M 10-K · filed 2020-03-02 |
| 2018-09-30 | $31.73M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $40.40M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $51.11M 10-Q · filed 2019-05-08 |
| 2017-12-31 | $70.95M 10-K · filed 2020-03-02 |
| 2017-09-30 | $84.41M 10-Q · filed 2018-11-09 |
| 2017-06-30 | $97.19M 10-Q · filed 2018-08-08 |
| 2017-03-31 | $66.45M 10-Q · filed 2018-05-10 |
| 2016-12-31 | $81.05M 10-K · filed 2019-03-05 |
| 2016-09-30 | $94.68M 10-Q · filed 2017-11-06 |
| 2016-06-30 | $109.00M 10-Q · filed 2017-07-31 |
| 2016-03-31 | $124.85M 10-Q · filed 2017-05-01 |
| 2015-12-31 | $140.72M 10-K · filed 2018-03-01 |
| 2015-09-30 | $163.84M 10-Q · filed 2016-11-09 |
| 2015-06-30 | $118.55M 10-Q · filed 2016-08-09 |
| 2015-03-31 | $129.68M 10-Q · filed 2016-05-10 |
| 2014-12-31 | $42.80M 10-K · filed 2018-03-01 |
| 2014-09-30 | $46.12M 10-Q · filed 2015-11-02 |
| 2014-06-30 | $53.00M 10-Q · filed 2015-08-10 |
| 2014-03-31 | $60.38M 10-Q · filed 2015-05-07 |
| 2013-12-31 | $68.20M 10-K · filed 2017-02-16 |
| 2013-09-30 | $23.63M 10-Q · filed 2014-10-30 |
| 2013-06-30 | $38.93M 10-Q · filed 2014-08-07 |
| 2013-03-31 | $55.66M 10-Q · filed 2014-05-08 |
| 2012-12-31 | $73.31M 10-K · filed 2016-02-24 |
| 2012-09-30 | $95.33M 10-Q · filed 2013-10-22 |
| 2012-06-30 | $110.39M 10-Q · filed 2013-08-08 |
| 2012-03-31 | $128.01M 10-Q · filed 2013-05-07 |
| 2011-12-31 | $104.71M 10-K · filed 2015-02-26 |
| 2011-09-30 | $118.93M 10-Q · filed 2012-11-08 |
| 2011-06-30 | $130.28M 10-Q/A · filed 2012-08-28 |
| 2011-03-31 | $124.04M 10-Q · filed 2012-05-03 |
| 2010-12-31 | $60.39M 10-K · filed 2014-03-03 |
| 2010-09-30 | $66.47M 10-Q · filed 2011-11-03 |
| 2010-06-30 | $73.66M 10-Q/A · filed 2011-08-09 |
| 2009-12-31 | $48.84M 10-K · filed 2013-03-18 |
| 2009-09-30 | $7.08M 10-Q · filed 2011-08-01 |
| 2008-12-31 | $11.38M 10-K · filed 2012-02-29 |
| 2003-09-09 | $0.00 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |